Oppenheimer Sticks to Their Buy Rating for Centene Corp (CNC)


Oppenheimer analyst Michael Wiederhorn maintained a Buy rating on Centene Corp (CNC) today. The company’s shares opened today at $59.50.

According to TipRanks.com, Wiederhorn is a top 100 analyst with an average return of 14.4% and a 66.4% success rate. Wiederhorn covers the Services sector, focusing on stocks such as Cross Country Healthcare, Addus Homecare Corp, and Community Health.

Currently, the analyst consensus on Centene Corp is a Strong Buy with an average price target of $78.88.

See today’s analyst top recommended stocks >>

Based on Centene Corp’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $16.56 billion and net profit of $241 million. In comparison, last year the company earned revenue of $12.81 billion and had a net profit of $230 million.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Centene Corp. engages in the provision of programs and services to government sponsored healthcare programs. It operates through the Managed Care and Specialty Services segments. The Medicaid Managed Care segment provides health plan coverage to individuals through government subsidized programs through Medicaid.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts